The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,385.00
Bid: 1,398.00
Ask: 1,401.00
Change: -21.00 (-1.49%)
Spread: 3.00 (0.215%)
Open: 1,406.00
High: 1,419.00
Low: 1,385.00
Prev. Close: 1,406.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

9 Nov 2022 16:46

RNS Number : 8869F
Indivior PLC
09 November 2022
 

BLOCK LISTING SIX MONTHLY RETURN

 

Date: November 9, 2022

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

LONG-TERM INCENTIVE PLAN

Period of return:

From:

May 10, 2022

To:

November 9, 2022

Balance of unallotted securities under scheme(s) from previous return:

7,272,394 ORDINARY SHARES OF US$0.10*

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

7,272,394 ORDINARY SHARES OF US$0.10*

Following Indivior PLC's share consolidation, which took effect on October 10 2022, the adjusted balance is 1,454,478 Ordinary Shares of US$0.50 each.

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

*Figures stated are before the Company's 5:1 share consolidation which took effect on 10 October 2022.

 

 

Date: November 9, 2022

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

UK SAVINGS RELATED SHARE OPTION PLAN

Period of return:

From:

May 10, 2022

To:

November 9, 2022

Balance of unallotted securities under scheme(s) from previous return:

870,149 ORDINARY SHARES OF US$0.10*

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

870,149 ORDINARY SHARES OF US$0.10*

Following Indivior PLC's share consolidation, which took effect on October 10 2022, the adjusted balance is 174,029 Ordinary Shares of US$0.50 each.

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

*Figures stated are before the Company's 5:1 share consolidation which took effect on 10 October 2022.

 

Date: November 9, 2022

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

U.S. EMPLOYEE STOCK PURCHASE PLAN

Period of return:

From:

May 10, 2022

To:

November 9, 2022

Balance of unallotted securities under scheme(s) from previous return:

3,647,590 ORDINARY SHARES OF US$0.10*

 

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

 

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

344,526 ORDINARY SHARES OF US$0.10*

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,303,064 ORDINARY SHARES OF US$0.10*

Following Indivior PLC's share consolidation, which took effect on October 10 2022, the adjusted balance is 660,612 Ordinary Shares of US$0.50 each.

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423940

 

*Figures stated are before the Company's 5:1 share consolidation which took effect on 10 October 2022.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBLBFTMTIMBIT
Date   Source Headline
13th Jun 20234:00 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSIndivior to Commence Trading on Nasdaq
7th Jun 20233:45 pmRNSHolding(s) in Company
2nd Jun 20235:17 pmRNSIndivior settles antitrust MDL with states and DC
1st Jun 20239:11 amRNSTotal Voting Rights
26th May 20234:20 pmRNSHolding(s) in Company
25th May 20232:30 pmRNSIndivior to Participate in Upcoming Conferences
24th May 20233:05 pmRNSHolding(s) in Company
23rd May 20236:05 pmRNSIndivior Files Form 20-F for US Listing
23rd May 20232:42 pmRNSHolding(s) in Company
23rd May 20238:30 amRNSHolding(s) in Company
23rd May 20237:00 amRNSUS FDA Approves OPVEE
12th May 20232:56 pmRNSHolding(s) in Company
10th May 20233:30 pmRNSDirector/PDMR Shareholding
10th May 202312:00 pmRNSBlock listing Interim Review
10th May 20238:51 amRNSHolding(s) in Company
4th May 20232:48 pmRNSResult of AGM
27th Apr 202312:00 pmRNS1st Quarter Results
25th Apr 20232:30 pmRNSIndivior to Participate in Conference
25th Apr 20239:26 amRNSHolding(s) in Company
20th Apr 20238:43 amRNSHolding(s) in Company
18th Apr 20238:09 amRNSHolding(s) in Company
17th Apr 20234:25 pmRNSHolding(s) in Company
11th Apr 20232:00 pmRNSNotice of Q1 Results
6th Apr 202312:24 pmRNSHolding(s) in Company
3rd Apr 20239:35 amRNSTotal Voting Rights
30th Mar 20232:37 pmRNSHolding(s) in Company
28th Mar 20233:21 pmRNSHolding(s) in Company
27th Mar 202311:42 amRNSAnnual Financial Report
24th Mar 20232:30 pmRNSDirector/PDMR Shareholding
23rd Mar 202310:02 amRNSBlock Listing of Shares
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
16th Mar 20232:30 pmRNSDirector/PDMR Shareholding
15th Mar 20232:30 pmRNSDirector/PDMR Shareholding
13th Mar 20234:04 pmRNSDirector/PDMR Shareholding
13th Mar 20232:36 pmRNSHolding(s) in Company
8th Mar 20239:42 amRNSDirector/PDMR Shareholding
6th Mar 20234:00 pmRNSDirector/PDMR Shareholding
6th Mar 202310:21 amRNSHolding(s) in Company
2nd Mar 20231:56 pmRNSIndivior Completes Opiant Transaction
2nd Mar 20238:43 amRNSCompletion of Share Repurchase Program
1st Mar 20234:35 pmRNSDirector/PDMR Shareholding
1st Mar 202310:09 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20234:18 pmRNSHolding(s) in Company
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20234:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.